Articles tagged with “ectd”

A 2026 operational guide to FDA study data standards version selection, including catalog dates, SDTM, SEND, ADaM, Define-XML, and rejection preflight controls.

Learn the key differences in regional eCTD submission guides from the FDA, EMA, & Health Canada. This guide covers Module 1 variations and the shift to eCTD v4.

A guide for emerging biotech on budgeting for Regulatory Information Management (RIM) and eCTD submissions. Covers cost structures, vendor solutions, and compli

Learn eCTD publishing best practices for compliant regulatory submissions. This guide covers technical standards, validation, and requirements from FDA, EMA, and other agencies.

Explore eCTD lifecycle management, the core process for updating regulatory dossiers. Learn about ICH standards, submission sequences, and the shift to eCTD v4.

Learn about the ICH M8 eCTD v4.0 submission specification. This guide covers its technical basis in HL7 RPS, file requirements, and global adoption timelines.

Learn eCTD sequence management for regulatory submissions: sequence numbering, lifecycle operations (new, replace, delete, append), FDA and EU rules, and eCTD v4.0 timelines.

Explore cloud-based regulatory submission tools for pharma. This guide covers eCTD software, RIM systems, compliance (21 CFR Part 11), benefits, and challenges.

Compare SaaS vs. on-premise eCTD solutions for pharma. This guide analyzes TCO, scalability, GxP compliance (21 CFR Part 11), and security for both models.

An overview of regulatory submission software for the life sciences. Learn how RIM systems & eCTD publishing tools streamline compliant filings to the FDA & EMA

Learn the most common eCTD validation errors that lead to technical rejection, where FDA treats a submission as not received. Covers structural, XML, and PDF issues.

Learn the eCTD publishing process for regulatory submissions, with eCTD v4.0 milestones: FDA optional since Sept 2024, EMA optional since Dec 2025, PMDA new drug applications from Apr 2026.

Learn about eCTD regional variations for global regulatory submissions. This guide compares Module 1 requirements from the FDA, EMA, Health Canada, and more.

Updated May 2026: Learn about common eCTD validation errors that lead to submission rejection. Covers FDA and EMA rules, eCTD v4.0 rollout, Health Canada Validation Rules v5.3, and strategies for first-pass compliance.

Learn the FDA's mandatory eCTD submission requirements, including key deadlines, technical standards, and the transition from eCTD v3.2.2 to v4.0 for NDAs, BLAs

A guide to regulatory submission quality control (QC). Explore best practices for eCTD dossier checklists to ensure compliance and avoid costly FDA/EMA rejectio

Learn eCTD validation requirements for FDA, EMA, Health Canada and PMDA submissions: technical specifications, business rules, common errors and validation tools.

Learn what eCTD viewer software is and why it's critical for regulatory submissions. This guide covers key features, technical capabilities, and tools.

Learn how Regulatory Information Management (RIM) systems help biotech firms manage compliance. This guide details core capabilities, submission planning, and t

Explore key challenges in pharmaceutical regulatory submissions, from legacy eCTD issues and CMC gaps to AI and structured data for faster drug approvals.

Comprehensive guide to Regulatory Information Management (RIM) systems and ISO IDMP standards, covering EMA PMS deadlines, eCTD v4.0 timelines, AI-powered RIM tools, and compliance strategies for life sciences organizations (updated March 2026).

Learn about Lorenz docuBridge, a key eCTD publishing software for biotech. Updated for 2026 with v25.2 features, eCTD v4.0 EU support, verifAI, and 2,000+ installations

An updated analysis of leading Regulatory Information Management (RIM) systems for 2026, covering Veeva Vault RIM, IQVIA SmartSolve RIM, ArisGlobal LifeSphere, Ennov, MasterControl, EXTEDO, and others, with the latest on eCTD 4.0, IDMP compliance, and AI-powered automation.

Examines the evolution of eCTD systems from specialized publishers for regulatory submissions to enterprise platforms that serve as a unified drug lifecycle archive, including the impact of eCTD v4.0, AI-powered RIM tools, and IDMP compliance.

This article explains how AI tools can validate regulatory dossiers, catch technical errors before submission, and minimize rework for emerging biotech companies. Updated with 2025-2026 developments including FDA's ELSA AI assistant, eCTD v4.0 validation updates, McKinsey benchmarks, and the latest Gemini 2.5 vs GPT-5 comparisons.